In ovalbumin (OVA)-induced asthmatic models, luteolin effectively alleviated airway inflammation, eosinophil infiltration, mucus hypersecretion, and airway hyperresponsiveness (AHR) through modulation of NF-κB signaling (Quan et al., 2024). Here, NFKB1 is linked to airway hyperresponsiveness.